These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor development. Oloumi A; Maidan M; Lock FE; Tearle H; McKinney S; Muller WJ; Aparicio SA; Dedhar S Breast Cancer Res; 2010; 12(3):R38. PubMed ID: 20565980 [TBL] [Abstract][Full Text] [Related]
4. The MMTV-Wnt1 murine model produces two phenotypically distinct subtypes of mammary tumors with unique therapeutic responses to an EGFR inhibitor. Pfefferle AD; Darr DB; Calhoun BC; Mott KR; Rosen JM; Perou CM Dis Model Mech; 2019 Jul; 12(7):. PubMed ID: 31213486 [TBL] [Abstract][Full Text] [Related]
5. Loss of Limb-Bud-and-Heart (LBH) attenuates mammary hyperplasia and tumor development in MMTV-Wnt1 transgenic mice. Ashad-Bishop K; Garikapati K; Lindley LE; Jorda M; Briegel KJ Biochem Biophys Res Commun; 2019 Jan; 508(2):536-542. PubMed ID: 30509497 [TBL] [Abstract][Full Text] [Related]
6. Pea3 transcription factors and wnt1-induced mouse mammary neoplasia. Baker R; Kent CV; Silbermann RA; Hassell JA; Young LJ; Howe LR PLoS One; 2010 Jan; 5(1):e8854. PubMed ID: 20107508 [TBL] [Abstract][Full Text] [Related]
7. Chromatin effector Pygo2 regulates mammary tumor initiation and heterogeneity in MMTV-Wnt1 mice. Watanabe K; Fallahi M; Dai X Oncogene; 2014 Jan; 33(5):632-42. PubMed ID: 23334328 [TBL] [Abstract][Full Text] [Related]
8. RARα1 control of mammary gland ductal morphogenesis and wnt1-tumorigenesis. Cohn E; Ossowski L; Bertran S; Marzan C; Farias EF Breast Cancer Res; 2010; 12(5):R79. PubMed ID: 20923554 [TBL] [Abstract][Full Text] [Related]
9. GPNMB augments Wnt-1 mediated breast tumor initiation and growth by enhancing PI3K/AKT/mTOR pathway signaling and β-catenin activity. Maric G; Annis MG; MacDonald PA; Russo C; Perkins D; Siwak DR; Mills GB; Siegel PM Oncogene; 2019 Jun; 38(26):5294-5307. PubMed ID: 30914799 [TBL] [Abstract][Full Text] [Related]
10. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966 [TBL] [Abstract][Full Text] [Related]
11. A mouse transgenic approach to induce β-catenin signaling in a temporally controlled manner. Mukherjee A; Soyal SM; Li J; Ying Y; Szwarc MM; He B; Kommagani R; Hodgson MC; Hiremath M; Cowin P; Lydon JP Transgenic Res; 2011 Aug; 20(4):827-40. PubMed ID: 21120693 [TBL] [Abstract][Full Text] [Related]
12. Differentiation generates paracrine cell pairs that maintain basaloid mouse mammary tumors: proof of concept. Kim S; Goel S; Alexander CM PLoS One; 2011 Apr; 6(4):e19310. PubMed ID: 21541292 [TBL] [Abstract][Full Text] [Related]
13. Rspo2/Int7 regulates invasiveness and tumorigenic properties of mammary epithelial cells. Klauzinska M; Baljinnyam B; Raafat A; Rodriguez-Canales J; Strizzi L; Greer YE; Rubin JS; Callahan R J Cell Physiol; 2012 May; 227(5):1960-71. PubMed ID: 21732367 [TBL] [Abstract][Full Text] [Related]
14. Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Li Y; Welm B; Podsypanina K; Huang S; Chamorro M; Zhang X; Rowlands T; Egeblad M; Cowin P; Werb Z; Tan LK; Rosen JM; Varmus HE Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15853-8. PubMed ID: 14668450 [TBL] [Abstract][Full Text] [Related]
15. Mitochondrial mass, a new metabolic biomarker for stem-like cancer cells: Understanding WNT/FGF-driven anabolic signaling. Lamb R; Bonuccelli G; Ozsvári B; Peiris-Pagès M; Fiorillo M; Smith DL; Bevilacqua G; Mazzanti CM; McDonnell LA; Naccarato AG; Chiu M; Wynne L; Martinez-Outschoorn UE; Sotgia F; Lisanti MP Oncotarget; 2015 Oct; 6(31):30453-71. PubMed ID: 26421711 [TBL] [Abstract][Full Text] [Related]
16. ErbB-beta-catenin complexes are associated with human infiltrating ductal breast and murine mammary tumor virus (MMTV)-Wnt-1 and MMTV-c-Neu transgenic carcinomas. Schroeder JA; Adriance MC; McConnell EJ; Thompson MC; Pockaj B; Gendler SJ J Biol Chem; 2002 Jun; 277(25):22692-8. PubMed ID: 11950845 [TBL] [Abstract][Full Text] [Related]
17. E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling. Yamada K; Hori Y; Inoue S; Yamamoto Y; Iso K; Kamiyama H; Yamaguchi A; Kimura T; Uesugi M; Ito J; Matsuki M; Nakamoto K; Harada H; Yoneda N; Takemura A; Kushida I; Wakayama N; Kubara K; Kato Y; Semba T; Yokoi A; Matsukura M; Odagami T; Iwata M; Tsuruoka A; Uenaka T; Matsui J; Matsushima T; Nomoto K; Kouji H; Owa T; Funahashi Y; Ozawa Y Cancer Res; 2021 Feb; 81(4):1052-1062. PubMed ID: 33408116 [TBL] [Abstract][Full Text] [Related]
18. Wnt signaling activation and mammary gland hyperplasia in MMTV-LRP6 transgenic mice: implication for breast cancer tumorigenesis. Zhang J; Li Y; Liu Q; Lu W; Bu G Oncogene; 2010 Jan; 29(4):539-49. PubMed ID: 19881541 [TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinases play an active role in Wnt1-induced mammary tumorigenesis. Blavier L; Lazaryev A; Dorey F; Shackleford GM; DeClerck YA Cancer Res; 2006 Mar; 66(5):2691-9. PubMed ID: 16510589 [TBL] [Abstract][Full Text] [Related]
20. Evolution of somatic mutations in mammary tumors in transgenic mice is influenced by the inherited genotype. Podsypanina K; Li Y; Varmus HE BMC Med; 2004 Jun; 2():24. PubMed ID: 15198801 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]